PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BlackRock Health Sciences Trust (BME)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US09250W1071

CUSIP

09250W107

Sector

Financial Services

IPO Date

Mar 29, 2005

Highlights

Market Cap

$467.85M

EPS (TTM)

$1.63

PE Ratio

22.21

Total Revenue (TTM)

-$383.86K

Gross Profit (TTM)

-$3.47M

EBITDA (TTM)

$45.97M

Year Range

$33.93 - $40.58

Short %

0.04%

Short Ratio

0.12

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
BME vs. BMEZ BME vs. BUI BME vs. FDUS BME vs. STRGX BME vs. VHT BME vs. VNQ BME vs. VOO BME vs. BST BME vs. SPY BME vs. XLE
Popular comparisons:
BME vs. BMEZ BME vs. BUI BME vs. FDUS BME vs. STRGX BME vs. VHT BME vs. VNQ BME vs. VOO BME vs. BST BME vs. SPY BME vs. XLE

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BlackRock Health Sciences Trust, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


300.00%400.00%500.00%600.00%700.00%NovemberDecember2025FebruaryMarchApril
623.32%
363.09%
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Returns By Period

BlackRock Health Sciences Trust had a return of -1.92% year-to-date (YTD) and 0.88% in the last 12 months. Over the past 10 years, BlackRock Health Sciences Trust had an annualized return of 6.12%, while the S&P 500 had an annualized return of 10.02%, indicating that BlackRock Health Sciences Trust did not perform as well as the benchmark.


BME

YTD

-1.92%

1M

-4.87%

6M

-9.54%

1Y

0.88%

5Y*

3.91%

10Y*

6.12%

^GSPC (Benchmark)

YTD

-8.25%

1M

-4.30%

6M

-7.20%

1Y

6.61%

5Y*

14.07%

10Y*

10.02%

*Annualized

Monthly Returns

The table below presents the monthly returns of BME, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20258.61%-0.80%-3.53%-5.63%-1.92%
20243.04%1.81%-0.88%-4.94%2.36%2.95%1.18%3.67%-0.63%-4.28%0.48%-4.31%-0.08%
20230.45%-3.12%0.22%3.08%-6.51%2.32%-1.00%0.38%-1.50%-7.07%6.96%5.71%-1.08%
2022-6.59%-3.77%5.93%-4.28%1.47%-2.64%3.86%-5.31%-5.50%9.92%5.41%-1.63%-4.63%
20211.02%-4.08%1.56%4.31%0.06%1.76%0.95%-0.10%-1.37%1.18%-3.12%5.25%7.25%
2020-2.79%-8.48%-3.18%11.97%6.36%-3.56%5.29%2.02%-0.77%-2.27%11.27%3.46%18.64%
20199.40%1.62%-0.30%-3.35%-4.88%8.00%0.90%-2.39%1.43%2.72%7.14%2.52%24.04%
2018-0.25%-2.46%0.24%0.60%5.61%5.47%4.19%4.57%2.69%-10.21%9.49%-11.51%6.38%
20174.94%3.88%1.73%1.75%0.52%5.40%0.82%-1.56%1.92%-0.72%1.41%1.11%23.10%
2016-9.28%-1.26%2.32%3.89%4.44%-5.88%1.91%-3.11%-0.63%-4.15%4.70%-4.57%-12.06%
2015-2.13%2.08%2.02%-4.37%7.96%-2.48%4.70%4.58%-18.82%9.95%3.51%4.70%8.69%
2014-1.58%10.46%-2.84%-3.95%2.77%1.73%-2.01%4.33%2.60%9.11%12.72%-1.97%34.12%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BME is 54, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BME is 5454
Overall Rank
The Sharpe Ratio Rank of BME is 5959
Sharpe Ratio Rank
The Sortino Ratio Rank of BME is 4747
Sortino Ratio Rank
The Omega Ratio Rank of BME is 4848
Omega Ratio Rank
The Calmar Ratio Rank of BME is 6060
Calmar Ratio Rank
The Martin Ratio Rank of BME is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for BlackRock Health Sciences Trust (BME) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BME, currently valued at 0.07, compared to the broader market-2.00-1.000.001.002.003.00
BME: 0.07
^GSPC: 0.28
The chart of Sortino ratio for BME, currently valued at 0.19, compared to the broader market-6.00-4.00-2.000.002.004.00
BME: 0.19
^GSPC: 0.53
The chart of Omega ratio for BME, currently valued at 1.03, compared to the broader market0.501.001.502.00
BME: 1.03
^GSPC: 1.08
The chart of Calmar ratio for BME, currently valued at 0.07, compared to the broader market0.001.002.003.004.00
BME: 0.07
^GSPC: 0.28
The chart of Martin ratio for BME, currently valued at 0.25, compared to the broader market-5.000.005.0010.0015.0020.00
BME: 0.25
^GSPC: 1.31

The current BlackRock Health Sciences Trust Sharpe ratio is 0.07. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of BlackRock Health Sciences Trust with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.07
0.28
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Dividends

Dividend History

BlackRock Health Sciences Trust provided a 7.74% dividend yield over the last twelve months, with an annual payout of $2.80 per share. The company has been increasing its dividends for 7 consecutive years.


6.00%8.00%10.00%12.00%14.00%16.00%18.00%$0.00$1.00$2.00$3.00$4.00$5.00$6.00$7.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$2.80$2.61$2.56$2.56$2.44$2.40$2.40$2.40$2.40$3.00$6.70$4.20

Dividend yield

7.74%6.87%6.32%5.87%5.03%5.04%5.65%6.58%6.58%9.45%17.04%9.83%

Monthly Dividends

The table displays the monthly dividend distributions for BlackRock Health Sciences Trust. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.26$0.26$0.26$0.26$1.05
2024$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.26$2.61
2023$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$2.56
2022$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$0.21$2.56
2021$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.21$0.21$0.21$2.44
2020$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2019$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2018$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2017$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$2.40
2016$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.80$3.00
2015$0.17$0.17$0.17$0.17$0.17$0.17$0.17$0.20$0.20$0.20$0.20$4.75$6.70
2014$0.43$0.00$0.00$0.43$0.00$0.00$0.14$0.50$0.17$2.54$4.20

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
BME: 7.7%
BlackRock Health Sciences Trust has a dividend yield of 7.74%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%
BME: 162.8%
BlackRock Health Sciences Trust has a payout ratio of 162.83%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-10.44%
-12.17%
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BlackRock Health Sciences Trust was 42.03%, occurring on Nov 20, 2008. Recovery took 263 trading sessions.

The current BlackRock Health Sciences Trust drawdown is 10.44%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-42.03%Jan 15, 2008217Nov 20, 2008263Dec 8, 2009480
-36.65%Feb 14, 202026Mar 23, 202073Jul 7, 202099
-25.47%Oct 3, 201856Dec 21, 2018235Nov 27, 2019291
-23.03%Aug 18, 2015123Feb 11, 2016350Jul 3, 2017473
-21.66%Jul 1, 201128Aug 10, 2011157Mar 26, 2012185

Volatility

Volatility Chart

The current BlackRock Health Sciences Trust volatility is 9.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
9.70%
13.54%
BME (BlackRock Health Sciences Trust)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how BlackRock Health Sciences Trust is priced in the market compared to other companies in the Asset Management industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
BME: 22.2
The chart displays the Price-to-Earnings (P/E) ratio for BME, comparing it with other companies in the Asset Management industry. Currently, BME has a P/E ratio of 22.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
2.04.06.08.010.0
BME: 0.0
The chart shows the Price/Earnings to Growth (PEG) ratio for BME compared to other companies in the Asset Management industry. BME currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
2.04.06.08.010.0
BME: 61.8
This chart shows the Price-to-Sales (P/S) ratio for BME relative to other companies in the Asset Management industry. Currently, BME has a P/S ratio of 61.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
2.04.06.08.010.0
BME: 0.9
The chart illustrates the Price-to-Book (P/B) ratio for BME in comparison with other companies in the Asset Management industry. Currently, BME has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for BlackRock Health Sciences Trust.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab